Company
Nanjing Immunophage Biotech Co., Ltd
Nanjing Immunophage Biotech Co., Ltd has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| IPG11406 | Phase 2 | Moderately to Severely Active Ulcerative Colitis (UC) |
Latest
No recent events.
Follow Nanjing Immunophage Biotech Co., Ltd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.